TIANYIN PHARMACEUTICAL
TPI
TPI was delisted on the 29th of April, 2016.
8 hedge funds and large institutions have $4.57M invested in TIANYIN PHARMACEUTICAL in 2013 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
33% more funds holding
Funds holding: 6 → 8 (+2)
5% more capital invested
Capital invested by funds: $4.37M → $4.57M (+$203K)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$71.8K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$41.2K |
| 3 |
SIM
Spark Investment Management
New York
|
+$37.4K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$13.6K |
| 5 |
BWFA
Baltimore-Washington Financial Advisors
Columbia,
Maryland
|
+$4.68K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAM
Pope Asset Management
Memphis,
Tennessee
|
-$131K |
| 2 |
CCB
Cutter & Co Brokerage
Ballwin,
Missouri
|
-$52K |
| 3 |
RIM
Regent Investment Management
Louisville,
Kentucky
|
-$7.16K |
| 4 |
U
UBS
Zurich,
Switzerland
|
-$6.13K |
| 5 |
FA
Financial Advantage
Columbia,
Maryland
|
-$1K |
TPI Hedge Fund Activity: Q4 2013 in Review
8 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in TIANYIN PHARMACEUTICAL (TPI) for Q4 2013, worth a combined $4.57M — up 4.6% from $4.37M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new TPI positions and 2 closed out — a net gain of 2 holders — while 1 added to existing stakes and 3 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $71.8K. The largest seller was Pope Asset Management, cutting an estimated $131K.
- 8 institutional investors held TIANYIN PHARMACEUTICAL (TPI) as of Q4 2013, up from 6 in Q3 2013.
- Funds reported $4.57M of TIANYIN PHARMACEUTICAL stock for Q4 2013, up 4.6% quarter-over-quarter.
- 4 funds opened new TIANYIN PHARMACEUTICAL positions in Q4 2013 and 2 closed out, a net change of +2 holders.
- The largest TIANYIN PHARMACEUTICAL buyer in Q4 2013 was Renaissance Technologies, an estimated $71.8K added.
- The largest TIANYIN PHARMACEUTICAL seller in Q4 2013 was Pope Asset Management, an estimated $131K sold.
Based on aggregated 13F filings for Q4 2013.